Table 1.
COVID-19 tested (n = 7,099) | COVID-19 positive (n = 1,439) | COVID-19 negative (n = 5,660) | Untested population (n = 494,838) | |
---|---|---|---|---|
Sex (Male) | 3,525 (49.7%) | 761 (52.9%) | 2,764 (48.8%) | 225,352 (45.5%) |
Age* | 69.11 (±8.65) | 68.22 (±9.19) | 69.34 (±8.49) | 68.24 (±8.10) |
White ethnicity | 6,498 (91.5%) | 1,242 (86.3%) | 5,256 (92.9%) | 465,681 (94.1%) |
BAME ethnicity | 562 (7.9%) | 185 (12.9%) | 377 (6.7%) | 26,429 (5.3%) |
BMI (kg/m2) | 27.66 [24.78, 31.13] | 27.97 [25.18, 31.50] | 27.58 [24.69, 31.02] | 26.7 [±24.13, 29.89] |
Smoking** | 3,663 (51.6%) | 732 (50.9%) | 2,931 (51.8%) | 221,478 (44.8%) |
Prior MI | 557 (7.8%) | 103 (7.2%) | 454 (8.0%) | 20,227 (4.1%) |
Diabetes | 1,029 (14.5%) | 241 (16.7%) | 788 (13.9%) | 38,046 (7.7%) |
Hypertension | 3,338 (47.0%) | 676 (47.0%) | 2,662 (47.0%) | 171,415 (34.6%) |
High cholesterol | 2,388 (33.6%) | 477 (33.1%) | 1,911 (33.8%) | 115,133 (23.3%) |
ACEi† | 1,117 (15.7%) | 227 (15.8%) | 890 (15.7%) | 50,635 (10.2%) |
ARB† | 418 (5.9%) | 87 (6.0%) | 331 (5.8%) | 20,416 (4.1%) |
Data are n (%), mean (standard deviation), or median [interquartile range]. COVID-19 data includes test results from 16/03/2020 to 14/06/2020 from hospital settings.
We report age of participants as of 01/04/2020.
Smoking includes current and previous smoking.
ACEi/ARB use is defined as a binary measure, defined as true if record of any of medications in Supplementary Table 2. ACEi, Angiotensin Converting Enzyme inhibitor; ARB, Angiotensin Receptor Blocker; BAME, Black, Asian, and Minority ethnic; BMI, body mass index; COVID-19, coronavirus 2019.